MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies. Issues related to Comparative Effectiveness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
| THOMAS JOHN FUSSARO | — |
Copyright/Patent/Trademark CPT
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
| THOMAS JOHN FUSSARO | — |
Medicare/Medicaid MMM
Medicare issues S. 301 Physician Payments Sunshine Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
| THOMAS JOHN FUSSARO | — |
Pharmacy PHA
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H. R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
| THOMAS JOHN FUSSARO | — |
Budget/Appropriations BUD
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
| THOMAS JOHN FUSSARO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.